欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/1764/001
药品名称Brinzolamide/Timolol STADA
活性成分
    • brinzolamide 10.0 mg/ml
    • timolol maleate 5.0 mg/ml
剂型Eye drops, suspension
上市许可持有人STADA Arzneimittel AG Germany
参考成员国 - 产品名称Sweden (SE)
Brinzolamide/Timolol Teva
互认成员国 - 产品名称
    • Germany (DE)
      Brinzolamid/Timolol AL 10 mg/ml + 5 mg/ml Augentropfensuspension
    • Netherlands (NL)
      Brinzolamide/Timolol CF 10 mg/ml + 5 mg/ml oogdruppels, suspensie
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Italy (IT)
    • Latvia (LV)
      Brinzolamide/Timolol Stada 10 mg/ml + 5 mg/ml acu pilieni, suspensija
    • Lithuania (LT)
      Brinzolamide/Timolol Teva 10 mg/5 mg/ml akių lašai (suspensija)
    • Estonia (EE)
      BRINZOLAMIDE/TIMOLOL STADA
许可日期2019/12/11
最近更新日期2024/05/27
药物ATC编码
    • S01ED51 timolol, combinations
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase